Debregeas Et Associes Pharma

Laboratoires Des Produits Ethiques Ethypharm

Laboratoire Des Produits Ethiques Ethypharm

Ethypharm, Inc.

Christophe Lebon

Pascal Suplie

Frantz Deschamps

Jennifer Jung

Dominique Marechal

Fabrice Leboeuf

David Olivier Paul

Emmanuel Guerin

Sandrine Salle

Julien Meissonnier

Immediate release, oral, pharmaceutical formulation comprising nalbuphine or a pharmaceutically acceptable salt thereof, and at least one hydrophilic granulation carrier, one hydrophilic binder and one lubricant.

Formulations containing nalbuphine and uses thereof

The present invention relates to a novel method for obtaining a pharmaceutical composition based on modafinil. This method consists of solubilizing S modafinil in a fluid in the supercritical state and then after expansion of said fluid, recovering S modafinil by causing it to be absorbed at the surface by a support appearing as granules. Said fluid may be COor another solvent and the support, anhydrous lactose or mannitol. Application of the pharmaceutical composition in the cases when increased short term alertness and over a short period is required for the consumer of the pharmaceutical composition.

Process for obtaining a modafinil-based pharmaceutical composition, resulting pharmaceutical composition and use thereof

Granules having a solid core on which an active ingredient is supported, the core being chosen preferably from among insoluble supports, the granules also having, supported on said the core, the following compounds: one or more coloring agents, one or more metallic pigments, one or more gas-releasing compounds, and optionally one or more embittering agents.

Pharmaceutical formulations to prevent the misuse of medicinal drugs

The present invention relates to a floating granule comprising a solid core, on which an active ingredient is supported and also comprising a compound which is capable of generating a gas discharge which is constituted by an alkaline agent, characterized in that it does not comprise an acid agent which is capable of generating a gas discharge.

Floating microgranules

The present invention relates to a granule of gamma-hydroxybutyric acid or of one of its pharmaceutically acceptable salts, characterized in that it comprises a solid core on which the gamma-hydroxybutyric acid or one of its salts is supported.

Composition based on gamma-hydroxybutyric acid

The invention relates to a drinkable ibuprofen solution wherein the soluble fraction of the active ingredient contained therein is less than 10% by weight in relation to the weight of the suspension.

Drinkable ibuprofen pharmaceutical suspension

The invention concerns ketoprofen microgranules with prolonged release each consisting of an active core containing ketoprofen coated with a polymeric film enabling prolonged release of the active principle and containing acrylic polymer coatings in a volume proportion substantially equal to 90/10.

Growing community of inventors

Rouvres, France

Christophe Lebon